Results 211 to 220 of about 329,411 (267)

The Association Between Use of Inhaled Corticosteroids and Long-Acting Beta2-Agonists During Pregnancy and Adverse Fetal Outcomes. [PDF]

Respirology
Wu YC, Wang IT, Huang HY, Wu CH.
europepmc   +1 more source

A retrospective study on the impact of the timing of diabetes diagnosis on maternal and fetal outcomes. [PDF]

Arch Gynecol Obstet
Zhou K, Chen W, Wu S, Li L, Xiang Y, Li Z.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

OUTCOME OF FETAL VENTRICULOMEGALY

The Lancet, 1984
Ventriculomegaly was diagnosed in 50 fetuses in the perinatal ultrasound unit of Yale-New Haven Medical Center. The outcomes were elective abortion, 13 (26%); antepartum death, 0 (0%); intrapartum death, 7 (14%); neonatal death within 24 h, 11 (22%); neonatal death after 24 h and within 28 days, 3 (6%); death after 28 days, 2 (4%); survival, 14 (28 ...
F A, Chervenak, C, Duncan, L R, Ment, J C, Hobbins, M, McClure, D, Scott, R L, Berkowitz   +6 more
openaire   +2 more sources

Fetal outcome in obstetrics cholestasis

International Journal of Gynecology & Obstetrics, 1988
Summary. Obstetric cholestasis has been associated with a high incidence of stillbirth and perinatal complications. Between 1975 and 1984, 83 pregnancies were complicated by cholestasis. Meconium staining occurred in 45%, spontaneous preterm labour in 44%, and intrapartum fetal distress in 22%.
Fisk, NM, Storey, Gnb
openaire   +5 more sources

Fetal Macrosomia and Pregnancy Outcomes

Obstetric Anesthesia Digest, 2009
Background:  Pregnancies with a macrosomic fetus comprise a subgroup of high‐risk pregnancies. There is uncertainty in the clinical management and outcomes of such pregnancies.Aim:  We sought to examine clinical management and maternal and fetal outcomes in pregnancies with macrosomic infants at Royal Brisbane and Women's Hospital (RBWH).Methods:  Data
Ju, Hong, Chadha, Yogesh, Donovan, Tim, O'Rourke, Peter   +3 more
openaire   +5 more sources

Fetal macrosomia — maternal risks and fetal outcome

International Journal of Gynecology & Obstetrics, 1990
AbstractTwo hundred eighty‐four macrosomic babies of 4000 g or over at birth were compared with an equal number of appropriate weight term infants, to identify maternal risk factors and fetal outcome. Maternal obesity, grand multiparity, diabetes mellitus and post‐maturity were the major maternal risks.
A A, Meshari, S, De Silva, I, Rahman
openaire   +2 more sources

Maternal micronutrients and fetal outcome

The Indian Journal of Pediatrics, 2004
Maternal micronutrient deficiency has been related to adverse fetal effects. It is believed that micronutrient supplementation during pregnancy may improve fetal and neonatal outcome. Despite biological plausibility, the evidence base for individual micronutrient benefit on neonatal morbidity, mortality, growth and development is patchy and often ...
Dheeraj, Shah, H P S, Sachdev
openaire   +2 more sources

Fetal gender and pregnancy outcome

The Journal of Maternal-Fetal & Neonatal Medicine, 2009
To assess the effect of fetal gender on pregnancy outcome.Retrospective study of all singleton pregnancies at a tertiary hospital during 1995-2006.Of the 66,387 women studied, 34,367 (51.8%) delivered male and 32,020 (48.2%) delivered female neonates. The rate of preterm delivery (as early as 29 weeks) was higher for male fetuses and was attributed to ...
Nir, Melamed, Yariv, Yogev, Marek, Glezerman   +2 more
openaire   +2 more sources

Immunosuppressive drugs and fetal outcome

Best Practice & Research Clinical Obstetrics & Gynaecology, 2014
Successful pregnancies have been reported in all types of solid-organ transplant recipients on a variety of immunosuppressive regimens. Immunosuppression is essential to maintain the transplanted organ and maternal health, thus the safety of these medications continues to be studied.
Coscia LA, Constantinescu S, Davison JM, Moritz MJ, Armenti VT   +4 more
openaire   +3 more sources

Fetal Outcomes of Elective Delivery

Clinical Obstetrics & Gynecology, 2014
Retrospective observational studies have suggested that delivery at or beyond 39 weeks has numerous neonatal benefits including less need for respiratory support, fewer neurodevelopmental delays and lower health care costs. This has lead governmental agencies, and professional organizations to endorse a policy of limiting elective delivery prior to 39 ...
Matthew K, Hoffman, Audrey A, Merriam, Deborah B, Ehrenthal   +2 more
openaire   +2 more sources